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Edited by Stuart FergusonAbstract Glucocorticoid and thyroid hormones (T3) are im-
portant for the development of the lungs’ Na+ absorbing
phenotype, which is essential for the integrated functioning of
the respiratory tract. Electrometric studies of H441 airway
epithelial cells conﬁrmed that dexamethasone increases apical
Na+ conductance (GNa) and demonstrated that T3 facilitates this
control over GNa. Assays of transcriptional activity showed that
dexamethasone caused concentration-dependent activation of the
human a-ENaC promoter (EC50  5 nM) but, despite its clear
eﬀect on GNa, T3 had no eﬀect upon the transcriptional response
to dexamethasone. The facilitation of Na+ transport may thus
reﬂect control over events downstream to transcription.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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During fetal life, ﬂuid is secreted into the lumen of the de-
veloping lung establishing a distending pressure that is crucial
to lung morphogenesis [1]. However, this liquid must be re-
moved from the lung by the time of birth, since the retention of
liquid in the alveolar space can impede oxygenation of the
blood. Indeed, such retention of fetal lung liquid is a compo-
nent of respiratory distress syndrome (RDS), the commonest
cause of death amongst premature infants in the developed
world (see, e.g., [2]). Studies on fetal lambs showed that liquid
is normally absorbed from the lungs during labor and birth
and established that this absorption is driven by active Naþ
transport [3–5]. Moreover, this process is dependent upon
epithelial Naþ channels [6], which are composed of three
subunits (a-, b- and c-ENaC) encoded by separate genes [7–9].
It is clear that a-ENaC is vital for lung function as artiﬁcial
deletion of this gene abolishes lung liquid clearance and thus
precipitates death from respiratory distress within 48 h of birth
[6], whereas deletion of b- or c-ENaC does not cause overt
pulmonary pathology (see review [10]).
Glucocorticoid hormones play an important role in pul-
monary physiology by controlling the development of the* Corresponding author. Fax: +44-1382-632-597.
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trolled expression of the a-ENaC gene appears to be an im-
portant part of this process [11–14]. However, administering
glucocorticoids to immature fetuses does not cause precocious
development of an absorptive phenotype unless given in con-
junction with thyroid hormone (T3) and so both hormone
classes are important to the development of pulmonary Naþ
absorption [15,16]. Although the mechanisms by which T3 can
contribute to the control of pulmonary Naþ transport are
virtually unknown, it has been suggested that this hormone
can augment the glucocorticoid-evoked activation of the a-
ENaC promoter [14] and so, in the present study, we explore
the eﬀects of T3 upon glucocorticoid-evoked Na
þ transport
[17,18] and a-ENaC transcription in an epithelial cell line
(H441) derived from the human airway.2. Methods
2.1. Electrometric studies
H441 cells were grown for 7 days on permeable culture membranes
(Costar Snapwells, 106 cells cm2) in a fully deﬁned medium prepared
using fetal bovine serum (8.5%) that had been extensively dialyzed to
remove hormones/growth factors (see [17]). This medium was supple-
mented with dexamethasone (0.3–300 nM) and/or 10 nM T3 as detailed
in the text; 10 nM T3 was used because previous studies of isolated rat
distal epithelial cells had revealed clear physiological eﬀects at this
concentration [19]. H441 cells can form polarized epithelial sheets
when grown on permeable supports (e.g., [13,17]) and previous work
has shown that these cultures respond to dexamethasone, a synthetic
glucocorticoid, with an increase in the rate of transepithelial Naþ
transport that reﬂects increased expression of a Naþ conductance
identical to that associated with heterologous co-expression of a-, b-
and c-ENaC [13,17,18]. In the present study, H441 cells in monolayer
culture were, therefore, mounted in Ussing chambers so that amilo-
ride-sensitive (10 lM) short circuit current (IAmil, a measure of trans-
epithelial Naþ transport) and apical Naþ conductance (GþNa) could be
measured using previously described methods [17].
2.2. Assay of a-ENaC transcriptional activity
The 50 end of the human a-ENaC gene (GenBank Accession No.
U81961) includes two transcription start sites that allow the synthesis
of two distinct a-ENaC transcripts (a-ENaC-1 and a-ENaC-2) [20–22].
In the present study, a 2.2 Kb sequence corresponding to nucleotides
)1388 to +830 (relative to the start site for the a-ENaC-1 transcript)
was ampliﬁed (PCR) from H441 cell genomic DNA using primers
(sense CACGGTACCACCCAGCACCCAGAGAGCAGACGAA,
antisense: ATACTCGAGCTGACCTCGAGCTGTGTCCTGATTC)
that included KpnI and XhoI sites in their 50 ends (underlined). This
fragment (designated KR1) which includes exon 1A, intron 1 and the
start site for the a-ENaC-2 transcript [22], was then cloned into the
KpnI/XhoI site of the pGL3-basic vector. This lies upstream to a
Photinus pyralis (ﬁreﬂy) luciferase gene so that activation of the KR1blished by Elsevier B.V. All rights reserved.
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monal regulation of this construct was explored by transfecting (4 lg
well1, Ca2PO4 co-precipitation) H441 cells on 12 well plates with the
basic pGL3 plasmid or the pGL3 plasmid containing the KR-1 se-
quence (pGL3-KR1). In each experiment, cells were also transfected
with a second plasmid (pRL-TK, 0.12 lg) incorporating a constitu-
tively active promoter upstream to a coelenterate (Renilla reniformis)
luciferase gene. The transfected cells were incubated for 18 h before
being glycerol shocked (15% v/v glycerol, 2 min at room temperature)
and, after a 4 h recovery period, stimulated with dexamethasone and/
or T3. The cells were then harvested, lysed and the amounts of Photinus
and Renilla luciferase isoforms produced were measured (Wallac 1420
Victor plate reading luminometer/Promega dual luciferase assay sys-
tem). We are aware that some authors have reported that glucocor-
ticoids can activate the pRL-TK plasmid [23] but, in the present study,
the highest dexamethasone concentration used (200 nM) had no dis-
cernible eﬀect upon Renilla luciferase formation and so this signal was
used to control for variations in transfection eﬃciency. Transcriptional
activities are normalized to the background activity determined in cells
expressing the empty pGL3 vector.Fig. 1. T3-evoked control over GNa. Apical Naþ conductance (GNa)
was measured in H441 cells, grown to conﬂuence on Costar Snapwell
membranes, by monitoring the amiloride sensitive (10 lM) currents
evoked by imposing inwardly directed Naþ gradients upon cultures
that had been basolaterally permeabilized by adding nystatin (75 lM)
to the solution bathing the apical side of the cell layer. Data are
means S.E.M., n ¼ 5, asterisks denote statistically signiﬁcant eﬀects
of T3 (*P < 0:05, ***P < 0:005).3. Results and discussion
3.1. Eﬀects of T3 and dexamethasone upon the spontaneous ISC
Electrometric studies (n ¼ 5) of cells maintained (7 days) in
medium supplemented with 10, 30 or 100 nM dexamethasone
conﬁrmed (e.g., [17]) that H441 cells become incorporated into
electrically resistive cell sheets in the presence of this hormone;
the transepithelial resistances (Rt of these cultured epithelia
were thus 334 76, 491 70, and 440 47 X cm2, respectively.
Moreover, as anticipated by earlier work [13,14,17] such cul-
tures generated a spontaneous short circuit current that was
almost completely (>90%) inhibited by adding 10 lMamiloride
to the solution bathing the apical side of the cell layer. Analysis
of these data showed that IAmil was larger in cells that had been
exposed to higher concentrations of dexamethasone (10 nM:
2.7 0.7 lA cm2, 30 nM: 6.8 1.6 lA cm2, and 100 nM:
12.9 2.0 lA cm2). Parallel studies of age-matched cells that
were exposed to 10 nM T3 as well as dexamethasone showed
that T3 did not aﬀect Rt (10 nM dexamethasone: 474 56
X cm2; 30 nM dexamethasone: 543 112 X cm2; and 100 nM
dexamethasone: 427 65 X cm2), demonstrating that this hor-
mone does not inﬂuence the formation of a coherent epithelial
layer. However, T3 clearly augmented IAmil in cells exposed to
10 nM (5.6 0.6 lA cm2, P < 0:001 compared with control
data presented above) and 30 nM (11.0 2.2 lA cm2,
P < 0:05) dexamethasone. Although T3 also seemed to enhance
the currents generated by cells treated with 100 nM dexa-
methasone (18.1 3.7 lA cm2), this eﬀect was not statistically
signiﬁcant (P < 0:1). As H441 cells do not transport signiﬁcant
amounts of Naþ if maintained in glucocorticoid-free medium
[17,18], these data conﬁrm [13,14,17] that dexamethasone
evokes a concentration-dependent stimulation of Naþ trans-
port in these cells and show that T3 can augment the responses
evoked by submaximal concentrations of dexamethasone.
3.2. The control of GNa
Transepithelial Naþ transport is normally restricted by the
rate at which Naþ can cross the apical membrane and our
earlier studies thus showed that the glucocorticoid-inducedNaþ
transport seen in H441 cells reﬂects an increase in GNa [17,18].
As the data presented above suggest that T3 may also inﬂuence
the conductive properties of this membrane, we explored the
eﬀects of this hormone upon the glucocorticoid-evoked increase
in GNa [17]. As anticipated [17], these experiments showed thatdexamethasone caused a concentration-dependent increase in
GNa but also established that this response was almost doubled
by 10 nM T3 (Fig. 1). Whilst these data are highly suggestive of
a potentiating interaction between the two hormones, this hy-
pothesis cannot be formally accepted in the absence of data that
deﬁne the eﬀects of T3 upon GNa in the absence of dexameth-
asone. However, undertaking such experiments was not
straightforward, since Rt must be >200X cm2 to allowGNa to be
measured and, in our hands [17], H441 cells do not become
incorporated into such resistive cell sheets in the absence of
glucocorticoids. It was therefore not possible to explore the
eﬀects of T3 upon GNa directly and so we used an alternative
approach in which cells were maintained in dexamethasone-
containing (200 nM) medium for 6 days in order to ensure the
formation of resistive cell layers. The cells (n ¼ 3) were then
divided into three groups that were respectively maintained in
control (i.e., hormone free), dexamethasone-containing (200
nM) or T3-containing (10 nM) medium for a further 48 h before
GNa was measured; this time interval was chosen because pilot
studies had shown that Rt fell below 200 X cm2 if cells were
deprived of dexamethasone for 72 or 96 h. These experiments
showed that in control cells (Rt ¼ 333 5 X cm2), GNa was
83 16 lS cm2 and this value was 20% of that measured in
dexamethasone-treated cells (376 46 lS cm2, P < 0:05,
Rt ¼ 408 42 X cm2). Withdrawal of dexamethasone thus
causes a fall in GNa an observation that accords with previous
data which have shown a rapid reduction in basal Naþ trans-
port under such conditions (e.g., [13]). Studies of cells main-
tained in T3-containing medium (Rt ¼ 284 44 X cm2) showed
that GNa was 145 30 lS cm2, a value that did not diﬀer sig-
niﬁcantly from control and which was 38% of that measured
in dexamethasone-treated cells (P < 0:01). Whilst these data
suggest strongly that T3 cannot sustain the dexamethasone-
induced increase in GNa the mean value of GNa measured in
T3-treated cells was greater than control and, although this was
not statistically signiﬁcant, we were concerned that this small
Fig. 2. Dexamethasone-induced activation of pGL3-KR1. (A) Luci-
ferase formation (24 h) in H441 cells (n ¼ 5) transfected with the empty
pGL3 vector or with pGL3-KR1. Cells expressing pGL3-KR1 were
either maintained under basal (i.e., unstimulated) conditions or ex-
posed to dexamethasone (200 nM); * statistically signiﬁcant (P < 0:05)
diﬀerence between cells expressing pGL3-KR1 and pGL3; y statisti-
cally signiﬁcant (P < 0:001) eﬀect of dexamethasone upon pGL3-KR1-
expressing cells. (B) Time course for dexamethasone-induced (200 nM)
activation of pGL3-KR1 (n ¼ 3). Data are normalized to the back-
ground expression level measured in parallel studies of cells expressing
pGL3. (C) Responses to a range of concentrations of dexamethasone
(3–200 nM, 16 h, n > 4 for each point) quantiﬁed under control con-
ditions and in the presence of 10 nM T3. The sigmoid curves were ﬁtted
to the experimental data using a least squares regression procedure
(GraFit 5, Erithacus Software), whilst the dashed line shows the ac-
tivity of the KR-1 construct in unstimulated cells. All data are
meansS.E.M.
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this possibility is accepted, then analysis of these data shows
that, at best, T3 can sustain 20% of the dexamethasone-in-
duced increase in GNa and this small eﬀect cannot account for
the large increases inGNa shown in Fig. 1. The present data thus
suggest strongly that the large T3-evoked increase in GNa seen
when cells are simultaneously exposed to both hormones
(Fig. 1) must reﬂect a potentiating interaction between the two
hormone classes.
Whilst the present data, in common with previous in vivo
studies [15,16], suggest that T3 augments the response to
dexamethasone, in the present study dexamethasone could still
increase GNa if administered without T3 see also [13,17,18].
The situation in H441 cells thus diﬀers from that described in
the fetal lamb, where exogenous glucocorticoids cannot cause
precocious maturation of lung liquid absorption unless ad-
ministered with T3 [15]. This discrepancy may imply that in
vitro studies can detect increases in GNa that are not large
enough to cause detectable liquid absorption in vivo. It is,
however, also worth noting that naturally occurring gluco-
corticoids were used in the in vivo studies [15], whilst dexa-
methasone was used in the present experiments. It is possible
that this synthetic glucocorticoid may act with greater eﬃcacy,
which may allow T3-independent events to be detected.
3.3. Assay of transcriptional activity
It is now well accepted that glucocorticoids control tran-
scription of the a-ENaC gene by activating a glucocorticoid
response element (GRE) in this gene’s promoter region and
this is thought to be an important part of the mechanism that
allows such hormones to control epithelial Naþ transport [12–
14,24]. Studies of rat a-ENaC promoter showed that although
T3 could not evoke transcription per se, it did enhance glu-
cocorticoid-evoked transcription [12], which suggests strongly
that the T3-evoked enhancement of GNa, which we now report,
may be due to increased a-ENaC transcription. We therefore
explored the eﬀects of dexamethasone and T3 on the tran-
scriptional activity of a 2.2 Kb gene fragment that includes
1.4 Kb of the upstream, promoter region of the human a-
ENaC gene (see Section 2).
The ﬁrst such experiments (Fig. 2A) showed that the basal
activity of this construct was only 6-fold greater than the
background activity measured using the empty pGL3 vector.
Such low intrinsic activity has been reported in earlier studies of
both the rat and human a-ENaC promoters [13,14,21]. How-
ever, exposing the cells to a concentration of dexamethasone
(200 nM, 24 h) that substantially increases GNa (present study,
[17]) increased transcriptional activity 10-fold (Fig. 2A).
More detailed studies of this response showed that this dexa-
methasone-induced transcription ﬁrst became evident after 2–4
h and reached a clear peak at 16 h (Fig. 2B). Fig. 2C shows the
results of experiments in which cells were exposed to a range of
dexamethasone concentrations (0.3–200 nM) for this length of
time. Analysis of these data showed that, under control con-
ditions, the concentration needed for half maximal activation
(EC50) was 4.7 0.3 nM and that maximal responses occurred
at concentrations above 30 nM; we are unaware of any previous
work that has studied the concentrations of dexamethasone
needed to activate this promoter. Fig. 2C also includes the re-
sults of experiments in which H441 cells were exposed to 10 nM
T3 in addition to dexamethasone and analysis of these data
showed that this hormone had no signiﬁcant eﬀect upon theEC50 for dexamethasone (3.7 0.3 nM) or upon the magnitude
of the response to maximally eﬀective concentrations of this
hormone (Fig. 2C).
3.4. Signiﬁcance of present ﬁndings
Our earlier studies of H441 cells [17,18] identiﬁed a gluco-
corticoid-dependent, apical Naþ conductance and it is now
clear that the induction of this conductance is augmented by T3.
This accords well with data from fetal lambs, which showed
that the development of the lungs’ Naþ absorbing phenotype is
blocked by fetal thyroidectomy [15,16]. However, whilst this
eﬀect was reversed by exogenous T3, administering T3 to im-
mature fetuses did not cause precocious maturation of an ab-
sorptive phenotype unless given in conjunction with a
glucocorticoid. It is therefore clear that both hormone classes
are important to the maturation of pulmonary Naþ absorption
and this raises the possibility that poor maturation of Naþ
absorption, as well as impaired lung growth and surfactant
synthesis, may contribute to increased incidence of respiratory
illness seen amongst congenitally hypothyroid infants [25].
Moreover, studies of hypothyroid rats have revealed an
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absorptive tissue, the distal colon, and this deﬁcit, which can be
corrected by exogenous T3, provides evidence of a more general
role for this hormone in the control of epithelial Naþ transport
[26]. However, despite its potential importance, the mechanisms
underlying this phenomenon are almost totally unknown.
The present assays of transcriptional activity conﬁrmed that
dexamethasone activates the a-ENaC promoter and extended
upon this earlier work by establishing the relationship between
transcriptional activity and the concentration of dexametha-
sone used. However, the most important result to emerge from
these experiments was that T3, at a concentration that doubles
the dexamethasone-induced increase in GNa cannot sustain the
dexamethasone-induced increase in GNa and also has no eﬀect
upon the corresponding activation of the human a-ENaC
promoter (Fig. 2). This failure to augment dexamethasone
induced transcription was surprising as structural analysis of
the rat [12] and the human [20] promoters has shown that each
contains at least 2 binding sites with the potential to allow T3
to regulate transcription and because earlier work had pro-
vided strong evidence of a potentiating interaction between
these hormones [12]. However, the present data refer to the
human gene, whereas the previous study [12] was undertaken
using the rat a-ENaC promoter and there are surprisingly
large diﬀerences between these sequences [12,21,22]. It is
therefore possible that the apparent discrepancy between these
studies (present study, [12]) may reﬂect species-speciﬁc diﬀer-
ences. Furthermore, the previously reported eﬀect of T3 was
documented in COS7 cells co-expressing heterologous gluco-
corticoid and thyroid hormone receptors [12], whilst the
present study reports eﬀects mediated by the endogenous re-
ceptors expressed by H441 cells. It is, therefore, possible that
potentiating interactions may only be seen in cells overex-
pressing these nuclear receptors.
The KR-1 promoter fragment used in the present study
starts at a point that is 1.4 Kb upstream to the a-ENaC-1
start site and thus includes the whole of intron 1 and the GRE
that has previously been shown to regulate transcription
[13,20]. The present data thus show that T3 cannot modulate
responses mediated via this regulatory element. It is, however,
still possible that (i) T3-sensitive elements lying further up-
stream may control transcription in vivo or (ii) that inhibitory
elements in intron-1 may override any stimulatory eﬀects.
However, it is important to remember that increased a-ENaC
transcription is only one of the mechanisms by which gluco-
corticoids can control GNa as PY domains in each of the ENaC
subunits allow a number of proteins, of which NEDD-4/2 is
the archetypical example, to bind to the channel complex and
target it for internalization and degradation. As well as
evoking a-ENaC transcription, glucocorticoids interact with
this pathway by controlling the expression of serum and glu-
cocorticoid regulated kinases (SGK-1, SGK-2, and SGK-3),
enzymes that can phosphorylate and thus inactivate NEDD-4/
2 [27]. This has the eﬀect of increasing GþNa by inhibiting the
internalization/degradation of ENaC [14,28]. A growing body
of evidence now shows that this is a centrally important
mechanism that allows epithelial Naþ transport to be con-
trolled by hormones/growth factors [27]. Moreover, it is clear
that this pathway does contribute to the control of pulmonary
Naþ transport (see, e.g., [14,29]).
T3-evoked augmentation of glucocorticoid-induced pul-
monary Naþ transport has now been documented in rat [30],sheep [15,16] and human (present study) cells, but the data
presented here suggest strongly that this can occur with no
increase in a-ENaC transcription. The potentiating interaction
between glucocorticoid and thyroid hormones may thus in-
volve a signaling pathway downstream to transcription (e.g.,
SGK-1, NEDD-4/2) or control over the expression of other
ENaC subunits.
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